院校生物安全委员会 (IBC) FAQs

   

研究常见问题
关闭所有全部展开

Your shipment may require permits from the Center for Disease Control (CDC), Department of Commerce (DOC) and/or United States Department of Agriculture (USDA).

A fundamental objective of any biosafety program is the “containment” of potentially harmful biological agents.

The term “containment” is used in describing safe methods, facilities and equipment for managing infectious materials in the laboratory environment where they are being handled or maintained.

The purpose of containment is to reduce or eliminate exposure of laboratory workers, 其他的人, and the outside environment to potentially hazardous agents. The use of vaccines may provide an increased level of personal protection. The risk assessment of the work to be done with a specific agent will determine the appropriate combination of these elements.

Four “Biosafety Levels ((BSL) have been developed. NJIT没有进行BSL4工作.

  • BSL-1: Suitable for work involving well characterized agents not known to cause disease in healthy adult humans and of minimal potential hazard to laboratory personnel and the environment.
  • BSL-2: Suitable for work involving agents of moderate potential hazard to personnel and the environment.
  • BSL-3: Suitable for work with infectious agents which may cause serious or potentially lethal disease as a result of exposure by the inhalation route.

在许多国家, 包括美国在内, infectious agents are categorized in risk groups based on their relative risk. Depending on the country and/or organization, this classification system might take the following factors into consideration:

  • 生物体的致病性
  • 传输方式和主机范围
  • Availability of effective preventive measures (e.g.、疫苗)
  • Availability of effective treatment (e.g.抗生素)
  • 其他因素

Risk group classifications are primarily used in the research environment as part of a comprehensive biosafety risk assessment. There are four (4) risk group designations:

  • 风险组别1 (RG1) agents are not associated with disease in healthy adult humans.
  • 风险组别2 (RG2) agents are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available.
  • 风险组别3 (RG3) agents are associated with serious or lethal human disease for which preventive or therapeutic interventions may be available.
  • 风险组别4 (RG4) agents are likely to cause serious or lethal human disease for which preventive or therapeutic interventions are not usually available.

NJIT provides compliance assurances to the National Institutes of 健康. One of these assurances is that laboratory inspections will be conducted periodically for all research involving recombinant DNA and/or biohazards.

Contact or your Environmental 健康 & 安全 Representative to set up an inspection at 973-596-3059. 欲了解更多信息，请访问 环境卫生署 & 安全.

研究 conducted at each location must undergo location-specific institutional (e.g., IBC) research risk reviews and grant approval. Grant approval is often dependent on IBC approval.

新的应用程序, 对延期的回应, and any amendments calling for significant changes to approved research require convened committee review and will be discussed at the subsequent 月度会议.

新申请截止日期, 对延期的回应, and any amendments calling for significant changes to approved research are 在我们的网站上.

读了 政策.

表格可在 研究处 网站.

NJIT provides both internal and external training opportunities. The internal training is offered by the NJIT Environmental 健康 and 安全. 欲了解更多信息，请访问: http://www5.申博太阳城.edu/environmentalsafety/.

NJIT也提供 花旗培训项目.